Ángel Chamorro Selected Research

fostriecin

1/2021

Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ángel Chamorro Research Topics

Disease

38	Stroke (Strokes) 07/2022 - 04/2011
33	Ischemic Stroke 07/2022 - 04/2011
10	Infarction (Infarctions) 07/2022 - 03/2012
8	Brain Ischemia (Cerebral Ischemia) 01/2022 - 05/2014
5	Hemorrhage 01/2020 - 01/2017
5	Ischemia 04/2019 - 05/2014
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 09/2016
3	Arterial Occlusive Diseases (Arterial Occlusive Disease) 07/2022 - 01/2019
3	Disease Progression 02/2021 - 03/2012
3	Thrombosis (Thrombus) 01/2020 - 05/2014
3	Hyperglycemia 01/2019 - 05/2015
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2021 - 05/2014
2	Hypothermia 01/2021 - 01/2016
2	Hypertension (High Blood Pressure) 12/2020 - 01/2019
2	Reperfusion Injury 07/2018 - 05/2011
1	Cerebral Infarction 04/2022
1	Hematoma 01/2022
1	Diabetes Mellitus 10/2021
1	Renal Insufficiency (Renal Failure) 10/2021
1	Neuroinflammatory Diseases 01/2021
1	Brain Edema (Cerebral Edema) 01/2021
1	Brain Injuries (Brain Injury) 12/2020
1	Transient Ischemic Attack 01/2020
1	Aphasia (Dysphasia) 01/2020
1	Embolic Stroke 01/2020
1	COVID-19 01/2020
1	Brain Infarction 01/2018
1	Edema (Dropsy) 01/2018
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 10/2017
1	Infections 02/2017
1	Pneumonia (Pneumonitis) 02/2017
1	Urinary Tract Infections (Urinary Tract Infection) 02/2017
1	Acidosis 01/2017

Drug/Important Bio-Agent (IBA)

16	Uric Acid (Urate)IBA 01/2021 - 05/2011
12	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 04/2011
8	Neuroprotective AgentsIBA 01/2021 - 01/2016
6	AntioxidantsIBA 01/2021 - 05/2011
4	Cytidine Triphosphate (CTP)IBA 07/2022 - 01/2020
4	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 05/2015
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2011
3	AntigensIBA 01/2020 - 03/2012
3	Pharmaceutical PreparationsIBA 07/2018 - 05/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2019
2	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 10/2017 - 05/2014
1	3K3A-APC proteinIBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2021
1	EnzymesIBA 01/2021
1	BuffersIBA 01/2021
1	fostriecinIBA 01/2021
1	cyclo(Arg-Pro) (CI 4)IBA 01/2021
1	otaplimastatIBA 01/2021
1	CytokinesIBA 01/2021
1	Verapamil (Calan)FDA LinkGeneric 01/2021
1	Caspase 3 (Caspase-3)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Factor Xa (Coagulation Factor Xa)IBA 01/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020
1	RivaroxabanIBA 01/2020
1	Evans Blue (Blue, Evans)FDA Link 01/2019
1	2- hydroxy- 5- (2,3,5,6- tetrafluoro- 4- trifluoromethyl- benzylamino)benzoic acidIBA 07/2018
1	Hormones (Hormone)IBA 01/2018
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	P-SelectinIBA 01/2018
1	cresyl violetIBA 01/2018
1	Complement System Proteins (Complement)IBA 10/2017
1	FicolinsIBA 10/2017
1	Serine Proteases (Serine Protease)IBA 10/2017
1	Peroxynitrous Acid (Peroxynitrite)IBA 01/2017
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2017
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2016
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2016
1	Natalizumab (Tysabri)FDA Link 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	Minocycline (Cyclops)FDA LinkGeneric 01/2016
1	AllantoinIBA 08/2015
1	argatroban (MPQA)FDA Link 05/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2012
1	Myelin Basic ProteinIBA 03/2012
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 03/2012
1	Myelin-Oligodendrocyte GlycoproteinIBA 03/2012
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 03/2012
1	nitronesIBA 05/2011
1	EdaravoneIBA 05/2011

Therapy/Procedure

23	Thrombectomy 07/2022 - 01/2016
19	Therapeutics 01/2021 - 05/2011
2	General Anesthesia 04/2022 - 10/2021
2	Thrombolytic Therapy 01/2013 - 04/2011
1	Punctures 10/2021
1	Embolectomy 01/2021
1	Time-to-Treatment 09/2016
1	Treatment Delay 09/2016
1	Emergency Treatment 01/2016
1	Intravenous Administration 01/2016
1	Lasers (Laser) 05/2014
1	Aftercare (After-Treatment) 01/2013